CO53 Comparison of Real-World Later-Line Treatment Outcomes in Patients with Microsatellite-Instability High (MSI-H) Versus Microsatellite-Stable (MSS) Metastatic Colorectal Cancer (mCRC) in the United States (US)
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.151
https://www.valueinhealthjournal.com/article/S1098-3015(22)00352-7/fulltext
Title :
CO53 Comparison of Real-World Later-Line Treatment Outcomes in Patients with Microsatellite-Instability High (MSI-H) Versus Microsatellite-Stable (MSS) Metastatic Colorectal Cancer (mCRC) in the United States (US)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00352-7&doi=10.1016/j.jval.2022.04.151
First page :
Section Title :
Open access? :
No
Section Order :
10120